Clinical Trials Browser

Phase 1 × Advanced Solid Neoplasms × Lymphoid × Clear all

NCT03338881 2023-02-08

A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma Malignancies

Phase 1 Withdrawn

Advanced Solid Neoplasms